Coronary Artery Bypass Graft Market Size

Coronary Artery Bypass Graft Market Size

Coronary Artery Bypass Graft Market size was valued at around USD 13.9 billion in 2023 and is anticipated to register a CAGR of 6.8% between 2024 and 2032. Coronary artery bypass graft (CABG) surgery is a medical procedure performed to treat coronary artery disease (CAD). During this surgical intervention, a surgeon creates new pathways for blood flow to the heart muscle by bypassing narrowed or blocked coronary arteries using grafts.

These grafts are segments of veins or arteries harvested from other parts of the patient's body, such as the leg or chest. By creating these bypasses, CABG surgery restores adequate blood supply to the heart, alleviating symptoms such as chest pain and reducing the risk of heart attack.
 

The increasing prevalence of cardiovascular disease has emerged as a significant driver for the market. For instance, according to the World Heart Federation (WHF), in 2021 an estimated 20.5 million people lost their lives due to cardiovascular diseases (CVDs). Therefore, there is a rising need for innovative approaches and technologies in the management and treatment of cardiovascular diseases (CVDs), particularly in aspects such as early detection, personalized medicine, minimally invasive procedures, and post-surgical care. These advancements aim to improve patient outcomes and reduce the burden of CVDs on global health.
 

Furthermore, the growing elderly population, advancements in technology, increasing prevalence of hypertension, and favorable reimbursement scenarios, among other contributing factors, stimulate the demand for the market.